• Philip Sharman, IFRF – ‘Introduction and IFRF Overview’

  • Authors: Philip Sharman
  • Publication date:

    September 2018

Summary

Philip Sharman, IFRF, UK

Philip is the part-time Director of IFRF in the new phase of its activity based in the UK.  In addition to this role, he also undertakes (or has undertaken recently) a number of non-executive and consultancy activities in the broad area of combustion and carbon capture & storage (CCS), including representing the UK on the Technical Group of the Carbon Sequestration Leadership Forum (CSLF) – a task he has done since its formation in 2003, chairing the Advanced Power Generation Technology Forum (APGTF), chairing the board of the UK CCS Research Centre, and being a member of a wide variety of advisory committees for various combustion-related initiatives.  He is currently an Honorary Professor of the University of Nottingham and a Visiting Professor at the University of Sheffield.

Since 2011 through his own company Evenlode Associates Ltd, Philip has been involved in a broad range of low-carbon energy technology activities (also including renewable energy, fuel cells, hydrogen systems, nuclear fission and fusion, energy storage, end-use energy demand) for various public and private sector organisations including EPRI Inc, Innovate UK, the UK Department of Business, Energy & Industrial Strategy (and its predecessors), the UK’s Research Councils, the Health & Safety Laboratory, the Global CCS Institute, Alstom Power, the Energy Knowledge Transfer Network, the UK Energy Research Centre and the universities of Nottingham, Sheffield and Oxford.

Prior to this, he was both the Director of Technology External Affairs and Director of Technology University Relations for Alstom Power, where his focus was to develop stronger linkages with governments, research organisations and technology providers worldwide and creating opportunities for Alstom’s power businesses.  A key part of this involved positioning Alstom as a major player in five different CO2 capture technologies, including collaborative R&D activities, pilot-scale validation trials and developing demonstration opportunities in Europe, North America and China.